Importantly, activated ILC2s upregulated α7nAChR expression more so than other immune cells, indicating that asthma patients having activated ILC2s might benefit greatly from a nicotinic agonist compound such as GTS-21. The gene discussed is CHRNA7; the disease is asthma.